CUDC-907: Clinical Trials

1 trial of CUDC-907, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow CUDC-907: new trials by email Literature Review of CUDC-907 trials Research Report on CUDC-907

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
CUDC-907 - Thyroid Neoplasms, Poorly Differentiated and Undifferentiated Thyroid Cancer
Phase 2TerminatedNational Cancer Institute (NCI)72016-12-222018-12-21

Conditions studied

Thyroid Carcinoma, Anaplastic (1)  ·  Thyroid Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

United States (1)

Top investigators

Naris Nilubol, M.D. (1)